Vimian Group Acquires Leading Companion Animal Health Specialty Pharmaceuticals Company in the UK

3 years ago

STOCKHOLM, SE / ACCESSWIRE / January 28, 2022 / Vimian Group (STO:VIMIAN)Vimian Group has today signed an agreement to acquire…

CENTR Brands Corp. Announces Q2 2022 Results

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company")…

Psyched Wellness Implements RSU Plan and Grant RSUS

3 years ago

Toronto, Ontario--(Newsfile Corp. - January 28, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or…

Helix BioPharma Corp. Reports Voting Results and Appointment of New Board Director

3 years ago

RICHMOND HILL, ON / ACCESSWIRE / January 28, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology…

ESO Identifies Key Fire Service Trends to Watch in 2022

3 years ago

Focus will be on staffing challenges, community engagement, provider wellness and evolving service delivery models AUSTIN, Texas--(BUSINESS WIRE)--ESO, the leading…

First Patient Recruited for Multi-Year Collaborative Primary Sclerosing Cholangitis (PSC) Pediatric Study Using Perspectum’s Imaging Technology to Help Predict Disease Progression and Guide Patient Management

3 years ago

SAN FRANCISCO--(BUSINESS WIRE)--#Healthcare--Perspectum announced recruitment of the first patient in a multi-center collaborative study to characterize Primary Sclerosing Cholangitis in…

CardieX Engages Integrous Communications as North American Investor Relations Advisor

3 years ago

IRVINE, CA / ACCESSWIRE / January 28, 2022 / CardieX Limited (ASX:CDX)(OTC PINK:CDEXF) ("CardieX" or the "Company",) a global health-technology…

Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark Office

3 years ago

ORLANDO, FL / ACCESSWIRE / January 28, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the receipt of an Issue Notification…

Sorrento Announces Its Oral SARS-CoV-2 Main Protease (Mpro) Inhibitor, STI-1558, Strongly Neutralizes Omicron

3 years ago

STI-1558, a novel oral Mpro inhibitor, effectively inhibits Omicron virus entry and replication in cells.STI-1558 is orally bioavailable with improved…

Clearmind Medicine Partners with Dr. Gabor Maté to Discuss Alcohol Use Disorder and Trauma in a Special Virtual Event on February 3

3 years ago

A renowned speaker, and bestselling author, Dr. Gabor Maté is highly sought after for his expertise on a range of…